litlas
Log inCreate account

Peter Reichardt

Active 1996–2024

124
Papers
29,911
Citations
83
h-index
121
i10-index

Citations

Citations per year for Peter Reichardt1926: 1 citations1960: 1 citations1992: 1 citations1993: 1 citations1994: 1 citations1996: 1 citations1997: 1 citations1998: 4 citations1999: 13 citations2000: 7 citations2001: 22 citations2002: 12 citations2003: 16 citations2004: 25 citations2005: 47 citations2006: 81 citations2007: 103 citations2008: 111 citations2009: 142 citations2010: 139 citations2011: 132 citations2012: 132 citations2013: 130 citations2014: 170 citations2015: 164 citations2016: 162 citations2017: 183 citations2018: 178 citations2019: 654 citations2020: 823 citations2021: 846 citations2022: 808 citations2023: 584 citations2024: 972 citations2025: 373 citations2026: 10 citations1927–1959: no citations, so these years are not shown1961–1991: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,705 citing papers, 18.8% of this breakdownChina: 999 citing papers, 11% of this breakdownGermany: 766 citing papers, 8.4% of this breakdownItaly: 643 citing papers, 7.1% of this breakdownUnited Kingdom: 579 citing papers, 6.4% of this breakdownFrance: 560 citing papers, 6.2% of this breakdownNetherlands: 407 citing papers, 4.5% of this breakdownSpain: 313 citing papers, 3.5% of this breakdownJapan: 313 citing papers, 3.4% of this breakdownCanada: 236 citing papers, 2.6% of this breakdownBelgium: 214 citing papers, 2.4% of this breakdownSwitzerland: 209 citing papers, 2.3% of this breakdown
0%18.8%Other 23.4%

Institutions

Fields

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology11.6%
  • Engineering3.5%
  • Immunology and Microbiology3.5%
  • Materials Science2.4%
  • Neuroscience1.9%
  • Other2.2%

Topics

  • Sarcoma Diagnosis and Treatment10.8%
  • Gastrointestinal Tumor Research and Treatment6.3%
  • Gastric Cancer Management and Outcomes4%
  • Bone Tumor Diagnosis and Treatments3.1%
  • Gastrointestinal disorders and treatments2.3%
  • Vascular Tumors and Angiosarcomas1.9%
  • Other71.6%

Coauthors

All papers

Open in search
  1. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Authors: Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Stéphanie Bolle, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Bernadette Brennan, Thomas Brodowicz, Angela Buonadonna, E. De Álava, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, Franca Fagioli, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, F. Gouin, Giovanni Grignani, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 989

  2. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

    Authors: Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales‐Barrera, Aude Fléchon, Şeyda Gündüz, Yohann Loriot, Alejo Rodríguez‐Vida, Ronac Mamtani, Evan Y. Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, D. Cascallar, Mirta Varela, Mauricio Fernández Lazzaro, Diego Kaen, Gabriela Gatica, David Hugo Flores, Agustín Falco, Matias Molina, F. Van Aelst, Christof Vulsteke, Brieuc Sautois, Jean‐Pascal Machiels, Denis Schallier, Leandro Brust, Liane Rapatoni, Sérgio Jobim Azevedo, GISELE LOPES MARINHO, João Paulo Holanda Soares, Carlos Dzik, Jamile Almeida Silva, André P. Fay, Joel Gingerich, Yves Fradet, Cristiano Ferrario, Kylea Potvin, Marie Vanhuyse, Mahmoud Abdelsalam, Susanna Cheng, Christian Caglevic, Felipe Reyes, José Luis Leal, Francisco Francisco, Carolina Ibáñez, Florence Joly, Brigitte Laguerre, Sylvain Ladoire, Aude Fléchon, Delphine Topart, Olivier Huillard, Stéphane Oudard, Marine Gross‐Goupil, Stéphane Culine, Yohann Loriot, Gwénaëlle Gravis, Peter Reichardt, Margitta Retz, Jan Herden, David G. Pfister, Carsten Ohlman, Michael Stöeckle, Manfred P. Wirth, Anja Lorch, Guenter Niegisch, Peter J. Goebell, Martin Boegemann, Axel S. Merseburger, Georgios Gakis, Jens Bedke, Andreas Neisius, Christian A. Thomas, Thomas Hoefner, András Telekes, Judit Kósa, János Révész, Gyorgy Bodoky, Tibor Csőszi, András Csejtei, Lajos Géczi, Ágnes Ruzsa, Zsuzsanna Kolonics, József Erfán, Ray McDermott, Richard Bambury, Avishay Sella, Stephen Jay Frank, Daniel Kejzman, Olesya Goldman, Eli Rosenbaum, Avivit Peer, Raanan Berger and 158 more - The Lancet Oncology 2021 cited by 648

  3. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Authors: Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina - European Journal of Cancer 2019 cited by 726

  4. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Paolo G. Casali, N. Abecassis, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 1,621

  5. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: Sandra J. Strauss, Anna Maria Frezza, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Stéphanie Bolle, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Bernadette Brennan, Thomas Brodowicz, Angela Buonadonna, E. de Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, Franca Fagioli, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Nathalie Gaspar, Silvia Gasperoni, Hans Gelderblom, F. Gouin, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, A. López Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Ruth Ladenstein, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 455

  6. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

    Authors: Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T.A. van der Graaf, Breelyn A. Wilky, Richard F. Riedel, Allison Lim, L. Mary Smith, Stephanie Moody, Steven Attia, Sant P. Chawla, Gina Z. D’Amato, Noah Federman, Priscilla Merriam, Brian A. Van Tine, Bruno Vincenzi, Charlotte Benson, Nam Q. Bui, Rashmi Chugh, Gabriel Tinoco, John A. Charlson, Palma Dileo, Lee Hartner, Lore Lapeire, F Mazzeo, Emanuela Palmerini, Peter Reichardt, Silvia Stacchiotti, Howard H. Bailey, Melissa Burgess, Gregory M. Coté, Lara E. Davis, Hari A. Deshpande, Hans Gelderblom, Giovanni Grignani, Elizabeth T. Loggers, Tony Philip, Joseph G. Pressey, Shivaani Kummar, Bernd Kasper - New England Journal of Medicine 2023 cited by 242

  7. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Paolo G. Casali, Jean‐Yves Blay, N. Abecassis, Jyoti Bajpai, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Thomas Brodowicz, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Armelle Dufresne, Mikael Eriksson, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, F. Gouin, Giovanni Grignani, Rick L. Haas, A.B. Hassan, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Alessandro Gronchi, Silvia Stacchiotti - Annals of Oncology 2021 cited by 563

  8. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Authors: Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan - The Lancet Oncology 2016 cited by 541

  9. Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

    Authors: Leo Kager, A. Zoubek, Ulrike Pötschger, Ulrike Kastner, Silke Flege, Beate Kempf‐Bielack, D. Branscheid, R. Kotz, M. Salzer‐Kuntschik, Winfried Winkelmann, Gernot Jundt, H. Kabisch, Peter Reichardt, Heribert Jürgens, Helmut Gadner, Stefan Bielack - Journal of Clinical Oncology 2003 cited by 957

  10. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Paolo G. Casali, N. Abecassis, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, S. Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 751

  11. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    Authors: George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, Jean‐Yves Blay, Piotr Rutkowski, Hans Gelderblom, Peter Hohenberger, Michael Leahy, Margaret von Mehren, Heikki Joensuu, Giuseppe Badalamenti, Martin E. Blackstein, Axel Le Cesne, Patrick Schöffski, Robert G. Maki, Sebastian Bauer, Binh Bui Nguyen, Jianming Xu, Toshirou Nishida, John Chung, Christian Kappeler, Iris Kuss, Dirk Laurent, Paolo G. Casali - The Lancet 2012 cited by 1,401

  12. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Paolo G. Casali, Stefan Bielack, N. Abecassis, Hannu T. Aro, Sebastian Bauer, R. Biagini, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Bernadette Brennan, Thomas Brodowicz, J.M. Broto, Laurence Brugières, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Catharina Dhooge, Mikael Eriksson, Franca Fagioli, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Nathalie Gaspar, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 641

  13. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Authors: Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan, Neyssa Marina, Gordana Jovic, Jane Hook, Mark Krailo, Mark C. Gebhardt, Zsuzsanna Pápai, James S. Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen M. Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul A. Meyers, Richard Görlick, Rein hard Windhager, K. Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula J. Schomberg, Per‐Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerß, Trude Butterfaß‐Bahloul, Carol D. Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark L. Bernstein - Journal of Clinical Oncology 2015 cited by 421

  14. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren - The Lancet Oncology 2020 cited by 407

  15. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

    Authors: Ralf‐Dieter Hofheinz, Kirsten Merx, Georg Martin Haag, Christoph Springfeld, Thomas J. Ettrich, K Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Margareta Siegler, Matthias P. Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf O. Bechstein, Peter Reichardt, H. Zwenneke Flach, Timo Gaiser, A. Battmann, Fuat Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten Oliver Goetze, Salah‐Eddin Al‐Batran - Journal of Clinical Oncology 2022 cited by 91

  16. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

    Authors: Rolf D. Issels, Lars H. Lindner, Jaap Verweij, Rüdiger Wessalowski, Peter Reichardt, Peter Wust, Pirus Ghadjar, Peter Hohenberger, Martin K. Angele, Christoph Salat, Željko Vujašković, Soeren Daugaard, Olav Mella, Ulrich Mansmann, Hans Roland Dürr, Thomas Knösel, Sultan Abdel-Rahman, M. Schmidt, Wolfgang Hiddemann, Karl‐Walter Jauch, Claus Belka, Alessandro Gronchi - JAMA Oncology 2018 cited by 322

  17. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke

    Authors: Jens Neumann, Monika Riek‐Burchardt, Josephine Herz, Thorsten R. Doeppner, Rebecca König, Heiko Hütten, Eloho Etemire, Linda Männ, Anika Klingberg, Thomas Fischer, Michael Görtler, Hans‐Jochen Heinze, Peter Reichardt, Burkhart Schraven, Dirk M. Hermann, Klaus G. Reymann, Matthias Gunzer - Acta Neuropathologica 2014 cited by 275

  18. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

    Authors: Silvia Stacchiotti, Aisha Miah, Anna Maria Frezza, Christina Messiou, Carlo Morosi, Augusto Caraceni, Cristina R. Antonescu, Jyoti Bajpai, Elizabeth H. Baldini, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Thomas Brodowicz, Dario Callegaro, E. De Alava, M. Deoras-Sutliff, Armelle Dufresne, Mikael Eriksson, Costantino Errani, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Christopher D.�M. Fletcher, Xavier García del Muro, Hans Gelderblom, Rebecca A. Gladdy, F. Gouin, Giovanni Grignani, J. Gutkovich, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Paul H. Huang, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Bernd Kasper, Akira Kawai, Axel Le Cesne, Franel Le Grange, Andreas Leithner, Hugh Leonard, A. Lopez Pousa, Javier Martín‐Broto, Ofer Merimsky, Priscilla Merriam, Rosalba Miceli, Olivier Mir, Michele Molinari, Michael Montemurro, Graziano Oldani, Emanuela Palmerini, Maria A. Pantaleo, S. Patel, Sophie Piperno‐Neumann, Chandrajit P. Raut, Vinod Ravi, Albiruni R. Abdul Razak, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Gonzalo Sapisochín, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, William D. Tap, Annalisa Trama, Andrew Tweddle, Winette T.A. van der Graaf, Michiel A. J. van de Sande, Winan J. van Houdt, G. van Oortmerssen, Andrew J. Wagner, Markus Wartenberg, Jayne Wood, Nadia Zaffaroni, Camilla Zimmermann, Paolo G. Casali, Angelo Paolo Dei Tos, Alessandro Gronchi - ESMO Open 2021 cited by 183

  19. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

    Authors: Penella J. Woll, Peter Reichardt, Axel Le Cesne, Sylvie Bonvalot, Alberto Azzarelli, Harald J. Hoekstra, Michael Leahy, Frits van Coevorden, Jaap Verweij, Pancras C.W. Hogendoorn, M. Ouali, Sandrine Marréaud, Vivien Bramwell, Peter Hohenberger - The Lancet Oncology 2012 cited by 588

  20. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

    Authors: Peter Thuss‐Patience, Albrecht Kretzschmar, Dmitry Bichev, T. Deist, Axel Hinke, Kirstin Breithaupt, Yasemin Doğan, Bernhard Gebauer, Guido Schumacher, Peter Reichardt - European Journal of Cancer 2011 cited by 615

  21. Risk–Benefit of Dexrazoxane for Preventing Anthracycline-Related Cardiotoxicity: Re-Evaluating the European Labeling

    Authors: Peter Reichardt, Marie‐Dominique Tabone, Jaume Mora, Bruce Morland, Robin L. Jones - Future Oncology 2018 cited by 155

  22. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study

    Authors: Sant P. Chawla, Jean‐Yves Blay, Piotr Rutkowski, Axel Le Cesne, Peter Reichardt, Hans Gelderblom, R. J. Grimer, Edwin Choy, Keith M. Skubitz, Leanne L. Seeger, Scott M. Schuetze, Robert M. Henshaw, Tian Dai, Danielle Jandial, Emanuela Palmerini - The Lancet Oncology 2019 cited by 253

  23. Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

    Authors: Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Peter Reichardt, Werner Hohenberger, Claus Ferdinand Eisenberger, Cornelie Haag, Murielle Mauer, Baktiar Hasan, John J. Welch, Katja Ott, Arnulf H. Hoelscher, Paul M. Schneider, Wolf O. Bechstein, H. Wilke, Manfred P. Lutz, Bernard Nordlinger, Eric Van Cutsem, Jörg R. Siewert, Peter M. Schlag - Journal of Clinical Oncology 2010 cited by 714

  24. One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor

    Authors: Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, J. Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah‐Eddin Al‐Batran, M. Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo‐Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari, Mika Leinonen, Thor Alvegård, Peter Reichardt - JAMA 2012 cited by 969